The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

The purpose of the present study is to investigate if endurance training can be used as a therapeutic action against the adverse metabolic disturbances and unfavourable changes in body composition that accompany the androgen deprivation therapy (ADT) treatment in prostate cancer patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Centre of Inflammation and Metabolism, Rigshospitalet

Copenhagen, 2100, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Prostate cancer patients receiving ADT for at least 3 months
Healthy age and BMI matched controls

Exclusion criteria

severe cardiovascular disease
severe arthritis
severe neuropathy
severe hypertension
therapy with antidiabetic agents
VO2max > 30.

Treatment and study plan

Endurance training

Behavioral

12 weeks of endurance training 3 times per week

Primary outcomes

Changes in body composition and insulin sensitivity in response to training

Time frame: Body composition and insulin sensitivity are measured at baseline and after 12 weeks of endurance training

Sponsors and collaborators

Lead sponsor

Inge Holm

Other

Collaborators

Herlev Hospital

Registry information

Official study title

The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving ADT

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Aug 31, 2012
Registry last updated: Sep 5, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed